Oncotarget
The cover for issue 48 of Oncotarget features Table 3, "Clinical responses per RECIST and clinical benefit rate based on age," by Subbiah, et al.
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome |
https://doi.org/10.18632/oncotarget.25612 Roberta Fenoglio, Savino Sciascia, Giulietta Beltrame, Paola Mesiano, Michela Ferro, Giacomo Quattrocchio, Elisa Menegatti, and Dario Roccatello |
28799-28804 |
Abstract | PDF | HTML | Order a Reprint |
Exhaled breath analysis for gastric cancer diagnosis in Colombian patients |
https://doi.org/10.18632/oncotarget.25331 Cristhian Manuel Durán-Acevedo, Aylen Lisset Jaimes-Mogollón, Oscar Eduardo Gualdrón-Guerrero, Tesfalem Geremariam Welearegay, Julián Davíd Martinez-Marín, Juan Martín Caceres-Tarazona, Zayda Constanza Sánchez-Acevedo, Kelvin de Jesus Beleño-Saenz, Umut Cindemir, Lars Österlund, and Radu Ionescu |
28805-28817 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
Comparison of platelet-albumin-bilirubin (PALBI), albumin-bilirubin (ALBI), and child-pugh (CP) score for predicting of survival in advanced hcc patients receiving radiotherapy (RT) |
https://doi.org/10.18632/oncotarget.25522 Connie H.M. Ho, Chi-Leung Chiang, Francis A.S. Lee, Horace C.W. Choi, Jeffery C.H. Chan, Cynthia S.Y. Yeung, J.J. Huang, Mark K.H. Chan, Oliver Blanck, and Frank C.S. Wong |
28818-28829 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
A single amino acid substitution in CXCL12 confers functional selectivity at the beta-arrestin level |
https://doi.org/10.18632/oncotarget.25533 Antonella Rigo, Isacco Ferrarini, Giulio Innamorati, and Fabrizio Vinante |
28830-28841 |
Abstract | PDF | HTML | Order a Reprint |
Older adults in phase I clinical trials: a comparative analysis of participation and clinical benefit rate among older adults versus middle age and AYA patients on phase I clinical trials with VEGF/VEGFR inhibitors |
https://doi.org/10.18632/oncotarget.25571 Ishwaria M. Subbiah, Chad Tang, Arvind Rao, Gerald S. Falchook, Vivek Subbiah, Apostolia M. Tsimberidou, Daniel Karp, Razelle Kurzrock, and David S. Hong |
28842-28848 |
Abstract | PDF | HTML | Order a Reprint |
Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p |
https://doi.org/10.18632/oncotarget.25599 Tetsuya Idichi, Naohiko Seki, Hiroshi Kurahara, Haruhi Fukuhisa, Hiroko Toda, Masataka Shimonosono, Yasutaka Yamada, Takayuki Arai, Yoshiaki Kita, Yuko Kijima, Yuko Mataki, Kosei Maemura, and Shoji Natsugoe |
28849-28865 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes |
https://doi.org/10.18632/oncotarget.25601 Elsa Maitre, Philippe Bertrand, Catherine Maingonnat, Pierre-Julien Viailly, Margaux Wiber, Dina Naguib, Véronique Salaün, Edouard Cornet, Gandhi Damaj, Brigitte Sola, Fabrice Jardin, and Xavier Troussard |
28866-28876 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma |
https://doi.org/10.18632/oncotarget.25608 Janine Hensel, Antoinette Wetterwald, Ramzi Temanni, Irene Keller, Carsten Riether, Gabri van der Pluijm, Marco G. Cecchini, and George N. Thalmann |
28877-28896 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis |
https://doi.org/10.18632/oncotarget.25622 Dai Chihara, Nathan H. Fowler, Yasuhiro Oki, Michelle A. Fanale, Loretta J. Nastoupil, Jason R. Westin, Luis E. Fayad, Sattva S. Neelapu, and Chan Yoon Cheah |
28897-28902 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients |
https://doi.org/10.18632/oncotarget.25627 Michael Constantin Kirchberger, Alvaro Moreira, Michael Erdmann, Gerold Schuler, and Lucie Heinzerling |
28903-28909 |
Abstract | PDF | HTML | Order a Reprint |
Marek’s disease virus oncoprotein Meq physically interacts with the chicken infectious anemia virus-encoded apoptotic protein apoptin |
https://doi.org/10.18632/oncotarget.25628 Andrew C. Brown, Vishwanatha R.A.P. Reddy, Joshua Lee, and Venugopal Nair |
28910-28920 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
V-ATPase-dependent repression of androgen receptor in prostate cancer cells |
https://doi.org/10.18632/oncotarget.25641 Yamhilette Licon-Munoz, Colleen A. Fordyce, Summer Raines Hayek, and Karlett J. Parra |
28921-28934 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts |
https://doi.org/10.18632/oncotarget.25649 Yukie Yoshii, Mitsuyoshi Yoshimoto, Hiroki Matsumoto, Hideaki Tashima, Yuma Iwao, Hiroyuki Takuwa, Eiji Yoshida, Hidekatsu Wakizaka, Taiga Yamaya, Ming-Rong Zhang, Aya Sugyo, Sayaka Hanadate, Atsushi B. Tsuji, and Tatsuya Higashi |
28935-28950 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma |
https://doi.org/10.18632/oncotarget.25652 Cory Pettit, Amy Webb, Steve Walston, Moumita Chatterjee, Wei Chen, Wendy Frankel, Carlo Croce, and Terence M. Williams |
28951-28964 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication |
https://doi.org/10.18632/oncotarget.25656 Sami Sebastian Khaznadar, Martin Khan, Elke Schmid, Sebastian Gebhart, Eva-Tessina Becker, Thomas Krahn, and Oliver von Ahsen |
28965-28975 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines |
https://doi.org/10.18632/oncotarget.25665 Mira Y. Gökyildirim, Ulrich Grandel, Katja Hattar, Gabriele Dahlem, Elena Schuetz, Florian H. Leinberger, Fabian Eberle, Ulf Sibelius, Friedrich Grimminger, Werner Seeger, Rita Engenhart-Cabillic, Ekkehard Dikomey, and Florentine S.B. Subtil |
28976-28988 |
Abstract | PDF | HTML | Supplementary Information | Order a Reprint |
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target |
https://doi.org/10.18632/oncotarget.25615 David M. Goldenberg, Rhona Stein, and Robert M. Sharkey |
28989-29006 |
Abstract | PDF | HTML | Order a Reprint |
Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment |
https://doi.org/10.18632/oncotarget.25626 David L. Elion, and Rebecca S. Cook |
29007-29017 |
Abstract | PDF | HTML | Order a Reprint |
Correction: Intake of red and processed meat and risk of renal cell carcinoma: a meta-analysis of observational studies |
https://doi.org/10.18632/oncotarget.25715 Shaojin Zhang, Qingwei Wang, and Juanjuan He |
29018-29018 |
Correction | PDF |
Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC